Paul Geyer, a successful Medtech Entrepreneur and experienced Board member. Over the past 20 years Paul founded and led two companies through their growth phase, in one case to a successful private exit and in the other case through growth as a public company with numerous acquisitions. Both companies have grown to be anchor medical device companies in the Vancouver area, employing more than 350 people. In 1991 he founded Mitroflow International Inc., a tissue heart valve company. Paul grew the company from 9 employees to more than 125 employees in 1999. In 1999 Paul sold Mitroflow to Sulzer Medica, for more than $50 mil. Paul’s leadership resulted in Mitroflow (Now Livanova) growing to more than 200 employees, making it one of the largest medical devices companies in the Vancouver area.
In 2001 Paul started Medical Ventures, a new specialty vascular device company where he is currently Chairman of the Board. From its inception to June 2008, Mr. Geyer held the position of CEO at Medical Ventures (now Neovasc) and was responsible for raising over $40 million in Equity financing and growing the company’s product portfolio through internal development and the acquisition of 3 other companies. Neovasc is a public company and the TSX and Nasdaq and continues to grow with operations in both Vancouver and Minneapolis, employing approximately 200 people.
In 2008 Paul began focusing on sharing is expertise to assist other Entrepreneurs to build successful businesses, through his involvement as a mentor or Board member. Mr. Geyer is an active Angel investor in technology and life science companies. In 2010 Paul was awarded the British Columbia Angel Investor of the year, and over the years has invested over $5mil in start-up businesses. He is an active supporter of the local Angel investment community, donating his time to assist local companies and investors through education programs and direct one-on-one mentoring. He is an active alumnus of the Kappa Sigma Fraternity. In 2011 Paul received the BC Life Sciences Leadership Award.
He is also focused on building the local community through his involvement as a Board member of both the Life Sciences and Technology associations, along with a number of non-profit community based organizations. Paul is actively engaged as a Philanthropist as the Chair of the Board of Social Venture Partners Vancouver. He is also involved in a number of other non-profit organizations including Science World Chairs Council, Entrepreneurship at UBC Board member, Project Somos Children’s Village and other local and International organizations.
Paul is currently the CEO of LightIntegra Technology Inc., a spin-off from Canadian Blood Services which has developed the ThromboLUX technology, used to determine platelet quality for blood transfusions.